ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run

ANI Pharmaceuticals CFO Stephen Carey sold 3,313 shares worth $285,000 on July 2, 2026, through a pre-established Rule 10b5-1 trading plan adopted in March. The sale represented only 2% of his direct holdings, leaving him with approximately $15.3 million in company stock. The transaction involved exercising options at $49.51 and selling at $86.00 per share. Despite the stock's 32% one-year return, the article characterizes this as routine portfolio management, noting the company's strong fundamentals including 20.5% Q1 revenue growth and raised full-year guidance.